LAS VEGAS--(BUSINESS WIRE)--
Enterprises, Inc. (OTCBB:MDCN) a
bio-pharmaceutical company focused on developing, and marketing
pharmaceutical grade cannabis to the emerging global medical marijuana
market is pleased to announce it has received all signatures and
approvals necessary for the Amendment Agreement previously announced on
May 5, 2014. This agreement sets forth the amended terms for the initial
acquisition of 50% of International Herbs Medical Marijuana (IHMML).
About Medican Enterprises Inc.
Medican Enterprises is a bio-pharmaceutical company focused on
developing, distributing and marketing pharmaceutical grade cannabis to
the emerging global medical marijuana market. It's wholly owned
subsidiary Medican Systems Inc. is an industry leader in the design,
construction and operation of Medical Marijuana and Cultivation Centers
across Canada. For more information visit: www.medicaninc.com.
Forward-Looking and Cautionary Statements
Certain statements contained herein contain "forward-looking
statements" within the meaning of Section 27A of Securities Act of 1933,
and Section 21E of the Securities Exchange Act of 1934. Statements in
this press release that are not purely historical are forward-looking
statements and include any statements regarding beliefs, plans,
expectations or intentions regarding the future. Such forward-looking
statements involve known and unknown risks, uncertainties and other
factors, which may cause the actual results, performance or achievements
of Medican Enterprises Inc. to be materially different from any future
results, performance or achievements expressed or implied by such
forward-looking statements. Given these uncertainties, readers are
cautioned not to place undue reliance on such forward-looking
statements. Medican Enterprises Inc. disclaims any obligation to update
or to announce publicly the results of any revision of the
forward-looking statements contained or incorporated by reference herein
to reflect future events or developments. Although we believe that any
beliefs, plans, expectations and intentions contained in this press
release are reasonable, there can be no assurance that any such beliefs,
plans, expectations or intentions will prove to be accurate. Investors
should consult all of the information set forth herein and should also
refer to the risk factors disclosure outlined in the reports and other
documents we file with the SEC, available at www.sec.gov.
Source: Medican Enterprises Inc.